Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 87%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,737
Total Claims
$2.0M
Drug Cost
931
Beneficiaries
$2,110
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+13%
Opioid rate vs peers
2.5% vs 2.2% avg
+50%
Cost per patient vs peers
$2,110 vs $1,411 avg
+26%
Brand preference vs peers
13.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.5%
Opioid Rate
397
Opioid Claims
$22K
Opioid Cost
10.3%
Long-Acting Rate
Brand vs Generic
Brand: 2,088 claims · $1.6M
Generic: 13,482 claims · $352K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 152 | $187K |
| Apixaban | 170 | $164K |
| Dulaglutide | 108 | $159K |
| Empagliflozin | 74 | $96K |
| Mirabegron | 86 | $70K |
| Fluticasone/Umeclidin/Vilanter | 80 | $64K |
| Dapagliflozin Propanediol | 58 | $58K |
| Rivaroxaban | 42 | $54K |
| Linagliptin | 38 | $49K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $41K |
| Linaclotide | 37 | $32K |
| Insulin Lispro | 21 | $31K |
| Tirzepatide | 26 | $30K |
| Semaglutide | 26 | $29K |
| Sitagliptin Phos/Metformin Hcl | 18 | $27K |
Prescribing Profile
Patient Profile
76
Avg Age
57%
Female
1.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About